These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 12922080

  • 1. Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis.
    Pinto EF, de Mello Cortezia M, Rossi-Bergmann B.
    Vaccine; 2003 Sep 08; 21(25-26):3534-41. PubMed ID: 12922080
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice.
    Pratti JE, Ramos TD, Pereira JC, da Fonseca-Martins AM, Maciel-Oliveira D, Oliveira-Silva G, de Mello MF, Chaves SP, Gomes DC, Diaz BL, Rossi-Bergmann B, de Matos Guedes HL.
    Parasit Vectors; 2016 Oct 06; 9(1):534. PubMed ID: 27716449
    [Abstract] [Full Text] [Related]

  • 3. The role of TLR9 on Leishmania amazonensis infection and its influence on intranasal LaAg vaccine efficacy.
    Pratti JES, da Fonseca Martins AM, da Silva JP, Ramos TD, Pereira JC, Firmino-Cruz L, Oliveira-Maciel D, Vieira TSS, Lacerda LL, Vale AM, Freire-de-Lima CG, Gomes DCO, Saraiva EM, Rossi-Bergmann B, de Matos Guedes HL.
    PLoS Negl Trop Dis; 2019 Feb 06; 13(2):e0007146. PubMed ID: 30802247
    [Abstract] [Full Text] [Related]

  • 4. Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan.
    Pinheiro RO, Pinto EF, de Matos Guedes HL, Filho OA, de Mattos KA, Saraiva EM, de Mendonça SC, Rossi-Bergmann B.
    Vaccine; 2007 Mar 30; 25(14):2716-22. PubMed ID: 16814903
    [Abstract] [Full Text] [Related]

  • 5. Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK.
    Pinto EF, Pinheiro RO, Rayol A, Larraga V, Rossi-Bergmann B.
    Infect Immun; 2004 Aug 30; 72(8):4521-7. PubMed ID: 15271911
    [Abstract] [Full Text] [Related]

  • 6. Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.
    Coelho EA, Tavares CA, Carvalho FA, Chaves KF, Teixeira KN, Rodrigues RC, Charest H, Matlashewski G, Gazzinelli RT, Fernandes AP.
    Infect Immun; 2003 Jul 30; 71(7):3988-94. PubMed ID: 12819086
    [Abstract] [Full Text] [Related]

  • 7. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX, Barçante TA, Vilela L, Tafuri WL, Afonso LC, Vieira LQ.
    Immunol Lett; 2006 May 15; 105(1):38-47. PubMed ID: 16466810
    [Abstract] [Full Text] [Related]

  • 8. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
    Iborra S, Carrión J, Anderson C, Alonso C, Sacks D, Soto M.
    Infect Immun; 2005 Sep 15; 73(9):5842-52. PubMed ID: 16113303
    [Abstract] [Full Text] [Related]

  • 9. A single intradermal administration of soluble leishmanial antigen and plasmid expressing interleukin-12 protects BALB/c mice from Leishmania major infection.
    Yamakami K, Akao S, Sato M, Nitta Y, Miyazaki J, Tadakuma T.
    Parasitol Int; 2001 Jul 15; 50(2):81-91. PubMed ID: 11438430
    [Abstract] [Full Text] [Related]

  • 10. Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants.
    Aebischer T, Wolfram M, Patzer SI, Ilg T, Wiese M, Overath P.
    Infect Immun; 2000 Mar 15; 68(3):1328-36. PubMed ID: 10678945
    [Abstract] [Full Text] [Related]

  • 11. Intranasal but not subcutaneous vaccination with LaAg allows rapid expansion of protective immunity against cutaneous leishmaniasis.
    Pereira Silva Bezerra I, Amaral Abib M, Rossi-Bergmann B.
    Vaccine; 2018 Apr 25; 36(18):2480-2486. PubMed ID: 29599090
    [Abstract] [Full Text] [Related]

  • 12. Protection of C57BL/10 mice by vaccination with association of purified proteins from Leishmania (Leishmania) amazonensis.
    Mora AM, Mayrink W, Costa RT, Costa CA, Genaro O, Nascimento E.
    Rev Inst Med Trop Sao Paulo; 1999 Apr 25; 41(4):243-8. PubMed ID: 10564919
    [Abstract] [Full Text] [Related]

  • 13. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
    Hugentobler F, Di Roberto RB, Gillard J, Cousineau B.
    Vaccine; 2012 Aug 24; 30(39):5726-32. PubMed ID: 22814408
    [Abstract] [Full Text] [Related]

  • 14. Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis.
    Coler RN, Skeiky YA, Bernards K, Greeson K, Carter D, Cornellison CD, Modabber F, Campos-Neto A, Reed SG.
    Infect Immun; 2002 Aug 24; 70(8):4215-25. PubMed ID: 12117930
    [Abstract] [Full Text] [Related]

  • 15. Intranasal vaccination with killed Leishmania amazonensis promastigotes antigen (LaAg) associated with CAF01 adjuvant induces partial protection in BALB/c mice challenged with Leishmania (infantum) chagasi.
    Leal JM, Mosquini M, Covre LP, Stagmiller NP, Rodrigues RR, Christensen D, de Matos Guedes HL, Rossi-Bergmann B, Gomes DC.
    Parasitology; 2015 Nov 24; 142(13):1640-6. PubMed ID: 26394776
    [Abstract] [Full Text] [Related]

  • 16. Intranasal vaccination with extracellular serine proteases of Leishmania amazonensis confers protective immunity to BALB/c mice against infection.
    de Matos Guedes HL, da Silva Costa BL, Chaves SP, de Oliveira Gomes DC, Nosanchuk JD, De Simone SG, Rossi-Bergmann B.
    Parasit Vectors; 2014 Sep 19; 7():448. PubMed ID: 25239157
    [Abstract] [Full Text] [Related]

  • 17. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S, Soto M, Carrión J, Alonso C, Requena JM.
    Vaccine; 2004 Sep 28; 22(29-30):3865-76. PubMed ID: 15364433
    [Abstract] [Full Text] [Related]

  • 18. DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous Leishmaniasis.
    Campbell K, Diao H, Ji J, Soong L.
    Infect Immun; 2003 Nov 28; 71(11):6270-8. PubMed ID: 14573646
    [Abstract] [Full Text] [Related]

  • 19. Immune responses induced by a Leishmania (Leishmania) amazonensis recombinant antigen in mice and lymphocytes from vaccinated subjects.
    Fernandes AP, Herrera EC, Mayrink W, Gazzinelli RT, Liu WY, de Costa CA, Tavares CA, Melo MN, Michalick MS, Gentz R, Nascimento E.
    Rev Inst Med Trop Sao Paulo; 1997 Nov 28; 39(2):71-8. PubMed ID: 9394518
    [Abstract] [Full Text] [Related]

  • 20. Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection.
    Colmenares M, Kima PE, Samoff E, Soong L, McMahon-Pratt D.
    Infect Immun; 2003 Jun 28; 71(6):3172-82. PubMed ID: 12761096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.